Olympus Corporation of the Americas (OCA) based in Center Valley, PA signed a definitive agreement to acquire Image Stream Medical, Inc., a healthcare systems integrator based in Littleton, MA. Olympus is a leading precision technology provider, designing and delivering innovative solutions for medical and surgical procedures, among other core businesses. This acquisition will further enable both companies to improve clinical …

Galatea Surgical announced the FDA 510k clearance of its GalaFORM™ 3D Surgical Scaffold (“GalaFORM 3D”) for use in plastic and reconstructive surgery. Based on Tepha’s proprietary P4HB™ bioresorbable polymer technology, GalaFORM 3D is the only 3-dimensionally contoured, surgical scaffold with a reinforcing rim, designed to uplift the body’s natural shape, provide easier placement and reduce procedure time. Galatea is a …

Bio-Optronics and Adventist Health System (AHS) announced the implementation and initial rollout of the Clinical Conductor Clinical Trial Management System (CTMS) at two of the faith-based health care system’s research institutes. This deployment, which included a CTMS-EMR integration with Cerner Millennium, will maximize process efficiency and enhance the organization’s overall research quality. A national leader in patient care, this implementation …

St. Mary’s Medical Center|SCL Health (St. Mary’s), the region’s top hospital, and Children’s Hospital Colorado (Children’s Colorado), one of the nation’s top 10 children’s hospitals, announced today they have entered into a formal Care Alliance collaboration to provide children and their families with the highest level of coordinated medical care as close to home as possible. St. Mary’s Medical Center …

Houston Health Ventures (HHV) has announced its early March investment in Allotrope Medical, Inc., a Houston-based medical device company bringing to market a novel ureter detection device for minimally invasive surgery.  HHV led the investment along with syndication support from the Houston Angel Network. David Franklin, Managing Director of HHV, comments, “We are very excited to add Allotrope Medical’s hand-held …

Lantheus Holdings announced the signing of a definitive license agreement (the “definitive agreement”) for the continued Phase III development and worldwide commercialization of flurpiridaz F 18, an investigational positron emission tomography (PET) myocardial perfusion imaging (MPI) agent that may improve the diagnosis of coronary artery disease (CAD), the most common form of heart disease. The definitive agreement follows the signing …

Surgical Information Systems (“SIS”), a leader in perioperative information systems, announced it has acquired SourceMed, a leader in ambulatory surgery center (ASC) software and services. The addition of SourceMed solutions to the award-winning SIS product suite, which includes SIS hospital and Amkai ambulatory products, positions the company to meet the needs of hospitals, ASCs, and ASC management companies. SourceMed develops …

Portal Instruments, a clinical stage medical device start-up company announced today that it has received ISO (International Organization for Standardization) 13485:2012 Certification by the National Standards Authority of Ireland (NSAI) certifying body. ISO 13485:2012, Quality Management Standard for Medical Devices is the international standard requirements for a comprehensive quality management system for the design and manufacture of medical devices. This …

Anaconda BioMed, a pre-clinical stage medical device company focused on the development of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS), today announced it has appointed Creganna Medical to develop, test and manufacture its ANCD BRAIN device as the product advances towards regulatory and clinical phases. “This is another important step for Anaconda Biomed to secure …

Becton, Dickinson & Co. said Sunday that it would acquire C.R. Bard Inc. for $24 billion, the latest merger of medical-supplies manufacturers. The deal values C.R. Bard at $317 a share, a 25.2% premium to the company’s share price as of Friday’s close. Bard shareholders will receive about $222.93 a share in cash and the balance in Becton Dickinson stock, …